Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
age-related immune system declines
Biotech
Apollo's mission to extend human health span gets $180M boost
Apollo has positioned itself to place a fresh round of bets on age-related disease biotechs, raising $180 million to funnel into companies.
Nick Paul Taylor
Dec 1, 2021 8:00am
Combating age-related cognitive decline via immune cells
Feb 5, 2020 9:00am
New Year biotech IPO hopefuls gun for $369M
Jan 2, 2018 4:56am
Novartis offloads phase 2 mTORC1 programs to PureTech
Mar 24, 2017 4:24am